Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country Study

Clinical trial NCT07746895 · RECRUITING

Trial details

NCT number: NCT07746895
Sponsor: Swedish Orphan Biovitrum
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

C3 Glomerulopathy (C3G)Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)

Start date: 2026-07-09
Primary completion: 2031-12-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.